Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients

Diabetes and Vascular Disease Research

Volumn 7, Issue 4, 2010, Pages 296-299

  Hamilton, Sandra J ^a   Chew, Gerard T ^a   Davis, Timothy Me ^a   Watts, Gerald F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Arterial compliance; niacin; statins; type 2 diabetes; vasodilatory function

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DRUG DOSE TITRATION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; FLUSHING; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAINTENANCE DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ARTERIOLES; COMPLIANCE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG THERAPY, COMBINATION; FOREARM; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; NIACIN; VASODILATION; VASODILATOR AGENTS;

EID: 79551717222     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.1177/1479164110376206     Document Type: Article

References (20)

1. Kearney PM, Blackwell L., Collins R., Keech A., Simes J., Peto R., et al. Efficacy of cholesterol lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008 ; 371: 117-25.
2. Collins R., Armitage J., Parish S., Sleigh P. and Peto R. MRC/ BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003 ; 361: 2005-16.
3. Watts GF, O'Brien SF, Silvester W. and Millar JA Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci 1996 ; 91: 567-73.
4. Woodman RJ, Playford DA and Watts GF Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: Associations with blood pressure and HDL cholesterol. Diabetes Res Clin Pract 2006 ; 71: 59-67. (Pubitemid 41821144)
5. McVeigh G., Brennan G., Hayes R., Cohn J., Finkelstein S. and Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 1993 ; 95: 424-30. (Pubitemid 23303073)
6. Weinberger MH, Fineberg NS, and Fineberg SE The influence of blood pressure and carbohydrate tolerance on vascular compliance in humans. Am Journal Hypertens 2002 ; 15: 678-82. (Pubitemid 34804272)
7. Perticone F., Ceravolo R., Pujia A., Ventura G., Iacopino S., Scozzafava A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001 ; 104: 191-6. (Pubitemid 32655837)
8. Grey E., Bratteli C., Glasser SP, Alinder C., Finkelstein SM, Lindgren BR et al. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 2003 ; 16: 265-9. (Pubitemid 36384752)
9. Kuvin JT, Ramet ME, Patel AR, Pandian NG, Mendelsohn ME and Karas RH A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: Enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J 2002 ; 144: 165-72. (Pubitemid 34734771)
10. Warnholtz A., Wild P., Ostad MA, Elsner V., Stieber F., Schinzel R. et al. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: Results of the randomised, double-blind, placebo-controlled INEF study. Atherosclerosis 2009 ; 204: 216-21.
11. Lee JMS, Robson MD, Yu LM, Shirodaria CC, Cunnington C., Kylintireas I. et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomised, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009 ; 54: 1787-94.
12. Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L., Miller M. et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009 ; 361: 2113-22.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 ; 32: S62-7.
14. Watts GF, Herrmann S., Dogra GK, Playford DA, Best JD, Thomas MAB et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int 2001 ; 60: 182-9. (Pubitemid 32587553)
15. Woodman RJ, Watts GF Measurement and application of arterial stiffness in clinical research: focus on new methodologies. Med Sci Monit 2003 ; 9: RA101-9.
16. Anderson RA, Evans ML, Ellis GR, Graham J., Morris K., Jackson SK et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001 ; 154: 475-83. (Pubitemid 32146622)
17. Teno S., Uto Y., Nagashima H., Endoh Y., Iwamoto Y., Omori Y. et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000 ; 23: 1401-06.
18. Vosper H. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol 2009 ; 158: 429-41.
19. Clinical Trial. AIM HIGH: Niacin plus statin to prevent vascular events. Available at: http://clinicaltrials.gov/ct2/show/NCT00120289?term=AIM- HIGH&rank=2. (Accessed 20 January 2010 ).
20. Clinical Trial. Treatment of HDL to reduce the incidence of vascular events. HPS2-THRIVE. Available at http://clinicaltrials.gov/ct2/show/ NCT00461630?term=HPS2-THRIVE&rank=1. (Accessed 20 January 2010 ).